Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a...
Vous n'êtes pas connecté
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine and The Rockefeller University identified a vulnerability that opens the door to new treatments.
Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a...
Blood clots form in response to signals from the lungs of cancer patients—not from other organ sites, as previously thought—according to a...
Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the insulin-producing cells and reversed diabetes in a...
Study of Respiratory Infections and The Effectiveness of Treatments Dr.Hiam Chemaitelly is a Lebanese Assistant Professor of Research in Population...
Accumulation of fat molecules is detrimental to the cell. Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS...
This year’s edition of the Weill Cornell Medicine-Qatar (WCM-Q) High School Research Competition (HSRC) brought together 214 students from 31 high...
FRIDAY, Feb. 21, 2025 -- Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet...
AI chipmaker Nvidia and research partners have created what they call the largest artificial intelligence system yet for biological research, the...
February 15, 2025 QUEENS, New York – A teen boy did not survive his injuries after being stabbed multiple times at a New York City McDonald’s on...